Compare Prologis Inc (PLD) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Prologis Inc vs Health Care Select Sector SPDR Fund — how do they compare? Prologis Inc trades at $135.37 (market cap $128.92B), while Health Care Select Sector SPDR Fund trades at $167.05. The key difference: Prologis Inc pays a 3.15% dividend while Health Care Select Sector SPDR Fund pays none, and Health Care Select Sector SPDR Fund is trading nearer its 52-week high, Prologis Inc nearer its low. Which is the better fit depends on your goals.
| PLD | XLV | |
|---|---|---|
Market Cap | $128.92B | — |
Sector | Real Estate | — |
52-Week High | $149.96 | $175.68 |
52-Week Low | $110.98 | $134.13 |
Enterprise Value | $163.66B | — |
Dividend Yield | 3.15% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Prologis (PLD) trades at $138.49, up 0.84% today, with a bearish technical signal but strong fundamentals. The stock has beaten earnings estimates in recent quarters, with Q3 2026 results expected soon. Revenue grew to $8.79B in 2025, and the company maintains high profit margins. Analyst consensus is bullish with a $160.13 price target, though technical indicators show near-term pressure with support at $137.
The outlook for PLD is positive due to consistent earnings beats and robust institutional interest, but risks include rising debt levels and market volatility. The stock offers growth potential from its real estate portfolio, yet investors should monitor debt-to-asset trends and economic conditions affecting REIT valuations.
XLV trades at $167.16, down 2.5% amid testing key support levels, with technical indicators showing mixed signals between bullish moving averages and bearish oscillators. The healthcare ETF maintains defensive appeal with upcoming dividend payments and sector rotation benefits during potential Fed tightening. Recent options activity shows increased put volume, suggesting some near-term caution among traders.
Healthcare sector strength and defensive positioning support XLV's long-term outlook, though near-term technical weakness and sector-specific headwinds from failed drug trials present risks. The ETF's low expense ratio and diversified healthcare exposure provide stability, with earnings momentum and FDA approvals driving fundamental strength.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Prologis Inc
Prologis was formed by the June 2011 merger of AMB Property and Prologis Trust. The company develops, acquires, and operates around 1 billion square feet of high-quality industrial and logistics facilities across the globe. The company also has a strategic capital business segment that has around $70 billion of third-party AUM. The company is organized into four global divisions (Americas, Europe, Asia, and other Americas) and operates as a real estate investment trust.
Read more on PLD →About Health Care Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →
